Search research articles
Contact Us
Filters
Showing results (11-20 of 479) with videos related to
Page
of 48
Sort By:
Annals of Internal Medicine
|
January 24, 2017
In patients with severe sepsis, hydrocortisone did not prevent progression to septic shock
Bram Rochwerg, Gordon Guyatt
Journal of Critical Care
|
April 10, 2026
Authors reply: "The diagnostic accuracy of serum procalcitonin for sepsis in critically ill adults. A systematic review and diagnostic meta-analysis"
Tanmoy Ghatak, Bram Rochwerg
Chest
|
January 10, 2021
POINT: Should Corticosteroids Be Routine Treatment in Early ARDS? Yes
Gianfranco Umberto Meduri, Bram Rochwerg
Annals of Internal Medicine
|
May 31, 2021
In COVID-19, tocilizumab reduces all-cause mortality at 28 d
Shannon M Fernando, Bram Rochwerg
Chest
|
October 7, 2023
Fluid Therapy in Sepsis: Does It Matter How Much?
Jonathan A Silversides, Bram Rochwerg
Chest
|
January 10, 2021
Rebuttal From Drs Meduri and Rochwerg
Gianfranco Umberto Meduri, Bram Rochwerg
Chest
|
January 11, 2023
Corticosteroids in Community-Acquired Pneumonia: In or Out?
Tyler Pitre, Bram Rochwerg, Dena Zeraatkar
JACC. Cardiooncology
|
September 6, 2024
Assessing the Certainty of Evidence on Efficacy and Safety of Anticoagulants for Cancer-Associated Thrombosis
Faizan Khan, Marc Carrier, Bram Rochwerg
Critical Care Medicine
|
June 13, 2024
The authors reply
Ben Forestell, Sameer Sharif, Bram Rochwerg
CJEM
|
February 3, 2021
Is dexamethasone an effective treatment for severe COVID-19 patients: Journal Club review
Kathryn Chan, Sameer Sharif, Bram Rochwerg
Page
of 48
Search research articles
Search
Showing results (11-20 of 479) with videos related to
Sort By:
Page
of 48
Annals of Internal Medicine
|
January 24, 2017
In patients with severe sepsis, hydrocortisone did not prevent progression to septic shock
Bram Rochwerg, Gordon Guyatt
Journal of Critical Care
|
April 10, 2026
Authors reply: "The diagnostic accuracy of serum procalcitonin for sepsis in critically ill adults. A systematic review and diagnostic meta-analysis"
Tanmoy Ghatak, Bram Rochwerg
Chest
|
January 10, 2021
POINT: Should Corticosteroids Be Routine Treatment in Early ARDS? Yes
Gianfranco Umberto Meduri, Bram Rochwerg
Annals of Internal Medicine
|
May 31, 2021
In COVID-19, tocilizumab reduces all-cause mortality at 28 d
Shannon M Fernando, Bram Rochwerg
Chest
|
October 7, 2023
Fluid Therapy in Sepsis: Does It Matter How Much?
Jonathan A Silversides, Bram Rochwerg
Chest
|
January 10, 2021
Rebuttal From Drs Meduri and Rochwerg
Gianfranco Umberto Meduri, Bram Rochwerg
Chest
|
January 11, 2023
Corticosteroids in Community-Acquired Pneumonia: In or Out?
Tyler Pitre, Bram Rochwerg, Dena Zeraatkar
JACC. Cardiooncology
|
September 6, 2024
Assessing the Certainty of Evidence on Efficacy and Safety of Anticoagulants for Cancer-Associated Thrombosis
Faizan Khan, Marc Carrier, Bram Rochwerg
Critical Care Medicine
|
June 13, 2024
The authors reply
Ben Forestell, Sameer Sharif, Bram Rochwerg
CJEM
|
February 3, 2021
Is dexamethasone an effective treatment for severe COVID-19 patients: Journal Club review
Kathryn Chan, Sameer Sharif, Bram Rochwerg
Page
of 48